Page 25 - CIBEREHD2016-ENG

Strategic Actions
Three Strategic Actions were granted in 2016:
FRG mice with humanized liver to study human liver diseases and drug-induced liver injury.
Principal Investigator: JC Fernández-Checa
GROUPS PARTICIPATING:
• Raúl Andrade Group
• Carmelo García Monzón Group
• Pere Gines Group (PIs, Joan Claria and Pau Sancho Bru)
• Xavi Forns Group
Use of human tissue in translational gastroenterology research.
Principal Investigator: P Clavé
COORDINATORS: M. Vicario (H. Vall d’Hebron), R. Farré (KU Leuven), D. Álvarez-Berdugo (H. Mataró)
GROUPS PARTICIPATING: J. Manyé (IGTP, Badalona), D. Bernardo (H. La Princesa, Madrid), A. Salas (H. Clínic, Barcelona), S. Lario (Parc Taulí, Sabadell), E. Piazuelo (H. Clínico, Zaragoza), F. Sánchez de Medina (Granada), D. Barrachina (U. Valencia), A. Carrasco (M. Terrassa).
Study of cell communication via exosomes in liver disease.
GROUPS PARTICIPATING:
• G0017 – Dr Juan Manuel Falcón-Pérez (JM Mato Group). Implementer of sub-project 1.
• G0082 – Dr Javier Vaquero (R Bañares) Group. Head of sub-project 2.
• G0026 – Dr Jordi Gracia-Sancho (J Bosch Group). Head of implementation of sub-projects 3 and 4.
• G0024 – Dr Agustín Albillos. Head of translational aspect of this proposal and of implementation of sub- project 5.
EHD
Transversal programmes 25